Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.56 |
| ▸ | DGKA | P23743 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | PAM | P19021 | 2/20 | 0.48 |
| ▸ | MGAM | O43451 | 1/20 | 0.48 |
| ▸ | SI | P14410 | 1/20 | 0.48 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.47 |
| ▸ | PGR | P06401 | 1/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31049888 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TRPA1DGKAALOX15 | |
| SCHEMBL31049893 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TRPA1DGKAALOX15 | |
| SCHEMBL31049856 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TRPA1DGKAALOX15 | |
| SCHEMBL318062 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TRPA1DGKAALOX15 | |
| SCHEMBL1005765 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TRPA1DGKAALOX15 | |
| SCHEMBL24597734 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TRPA1DGKAALOX15 | |
| SCHEMBL3862786 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TRPA1DGKAALOX15 | |
| SCHEMBL47126 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TRPA1DGKAALOX15 | |
| SCHEMBL1703446 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TRPA1DGKAALOX15 | |
| SCHEMBL31049851 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TRPA1DGKAALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119613646-A | Electrochromic material based on organic framework structure and electrochromic device thereof | 宁波祢若电子科技有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-115850618-A | Dynamic cross-linked azobenzene liquid crystal elastomer with linear/star SBS block copolymer as main chain and preparation method thereof | 大连理工大学 | 2023-03-28 | — | — | CN | claimed |
| US-12570901-B2 | Cured product, curable resin composition, optical member, lens, diffractive optical element, multilayer diffractive optical element, and compound | FUJIFILM CORPORATION (JP) | 2026-03-10 | — | — | US | disclosed |
| US-20250361250-A1 | FLUORINE-CONTAINING SILANE COMPOUND | DAIKIN INDUSTRIES, LTD. (JP) | 2025-11-27 | — | — | US | disclosed |
| US-20250340517-A1 | HIGH-DIELECTRIC CONSTANT ZWITTERIONIC LIQUIDS | PENN STATE RES FOUND (US) | 2025-11-06 | — | — | US | disclosed |
| EP-4561585-A1 | IP4-4,6 SUBSTITUTED DERIVATIVE COMPOUNDS FOR USE IN THE TREATMENT, INHIBITION OF PROGRESSION, AND PREVENTION OF ECTOPIC CALCIFICATION | Sanifit Therapeutics S.A. (ES) | 2025-06-04 | — | — | EP | disclosed |
| EP-4562019-A1 | IP5 SUBSTITUTED COMPOUNDS | Sanifit Therapeutics S.A. (ES) | 2025-06-04 | — | — | EP | disclosed |
| EP-4269396-B1 | COMPOUND, CORROSION INHIBITOR, AND LUBRICANT COMPOSITION | IDEMITSU KOSAN CO (JP) | 2025-05-14 | — | — | EP | disclosed |
| CN-117659003-B | Berberine derivative and preparation method and application thereof | 西南大学 | 2024-11-26 | — | — | CN | disclosed |
| WO-2024172034-A1 | FLUORINE-CONTAINING SILANE COMPOUND | ダイキン工業株式会社 | 2024-08-22 | — | — | WO | disclosed |
| CN-115003708-B | Cured product, curable resin composition, optical member, lens, diffractive optical element, multilayer diffractive optical element, and compound | 富士胶片株式会社 | 2024-07-09 | — | — | CN | disclosed |
| US-4933157-A | IMAGING AGENTS FOR ADRENAL GLANDS | THE UNIVERSITY OF MICHIGAN (US) | 1990-06-12 | — | — | US | disclosed |
| EP-0359197-A1 | Antihypercholesterolemic 4,5-diaryl-2-substituted thioimidazoles | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1990-03-21 | — | — | EP | disclosed |
| US-4900744-A | Antihypercholesterolemic 4,5-diaryl-2-substituted thioimidazoles | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-02-13 | — | — | US | disclosed |
| US-4873075-A | SITE-SPECIFIC TO LIVER AND HEPATOCYTE; SCINTIGRAPHY IMAGING | THE UNIVERSITY OF MICHIGAN (US) | 1989-10-10 | — | — | US | disclosed |
| EP-0303177-A2 | Polymers having functional groups | BASF Aktiengesellschaft (DE) | 1989-02-15 | — | — | EP | disclosed |
| EP-0097719-B1 | PROCESS FOR PRODUCING HIGHER DIBASIC ACID DIMETHYL ESTER | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1987-06-03 | — | — | EP | disclosed |
| US-4525251-A | DIMETHYL SEBACATE, BRASSYLATE, OR THAPSATE; BATCH ELECTROLYTIC CON | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1985-06-25 | — | — | US | disclosed |
| EP-0097719-A1 | PROCESS FOR PRODUCING HIGHER DIBASIC ACID DIMETHYL ESTER | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1984-01-11 | — | — | EP | disclosed |
| US-3954902-A | QUATERNARY AMMONIUM UNITS, MELT SPINNING | RHONE-POULENC-TEXTILE (FR) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570901-B2 | Cured product, curable resin composition, optical member, lens, diffractive optical element, multilayer diffractive optical element, and compound | POLA1, POLR2A, POLR2B | CYP1A2 3323/4885ALDH1A1 1861/4885TRPA1 3190/4885 |
| US-20250340517-A1 | HIGH-DIELECTRIC CONSTANT ZWITTERIONIC LIQUIDS | KCNH3, KCNN2, KCNN1 | CYP1A2 4150/4885ALDH1A1 1713/4885TRPA1 351/4885 |
| US-20250361250-A1 | FLUORINE-CONTAINING SILANE COMPOUND | FLI1, AFF1, RFT1 | CYP1A2 428/4885ALDH1A1 879/4885TRPA1 3963/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.